FDA declines to approve Allergan's Esmya Medical Dialogues Bureau24 Aug 2018 9:45 AM ISTAllergan Plc said U.S. health regulators had declined to approve Esmya, its treatment for abnormal uterine bleeding in women with uterine fibroids,...